In this study, we found a critical role of CCR5 signaling in the pathogenesis of BPD and demonstrated that the expression of CCR5 and its ligands was significantly increased in infants with BPD, as well as in an LPS-induced rat model of BPD, which had never been previously reported. The gene discussed is CCR5; the disease is bronchopulmonary dysplasia.